跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
COOPER A.R. - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
COOPER A.R.
Authorized
STANDARD
COOPER A.R.
Coopervision Inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
9b37fab41cf71b49
Company
Coopervision Inc.
Type
Standard
Approval Details
Approval Id
9b37fab41cf71b49
Drug Approval Canada Name
COOPER A.R.
Product Name
COOPER A.R.
Status
Cancelled Post Market
Status Date
1998-03-12
Original Market Date
1996-08-14
Din
02174243
Drug Class
Human
Dosage Form
Drops
Route Of Administration
Ophthalmic
Schedule
OTC
Ahfs
04:04.08
Aig Number
0203290001
Company Name
Coopervision Inc.
Company Address
100 Mcpherson Street, Markham, Ontario, Canada, L3R 3V6
Company Detail Path
/organization/coopervision-inc-united-states
Company Information
Pharmaceutical Company Name
Coopervision Inc.
Country Name
United States
Province Name
California
City Name
pleasanton,california,country_us
Address
5870 Stoneridge Dr Ste 1
Active Ingredients
NAPHAZOLINE HYDROCHLORIDE
.5 MG / ML
ANTAZOLINE PHOSPHATE
5 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
9b37fab41cf71b49
Type
Standard
Back to Health Canada Approvals